UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors

Annals of oncology, 2014-08, Vol.25 (8), p.1656-1663

2014

Volltextzugriff (PDF)

Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 1999-09, Vol.91 (17), p.1475-1479

1999

Volltextzugriff (PDF)

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

Journal of medical genetics, 2011-01, Vol.48 (1), p.64-68

2011

Volltextzugriff (PDF)

Germline E-cadherin mutations in familial lobular breast cancer

Journal of medical genetics, 2007-11, Vol.44 (11), p.726-731

2007

Volltextzugriff (PDF)

Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1

Journal of medical genetics, 2000-09, Vol.37 (9), p.641-645

2000

Volltextzugriff (PDF)

Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome

Science (American Association for the Advancement of Science), 1999-12, Vol.286 (5449), p.2528-2531

1999

Volltextzugriff (PDF)

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Annals of oncology, 2018-01, Vol.29 (1), p.154-161

2018

Volltextzugriff (PDF)

Germ-line p53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers

Cancer epidemiology, biomarkers & prevention, 2001-02, Vol.10 (2), p.83-87

2001

Volltextzugriff (PDF)

Multiple primary cancers in families with Li-Fraumeni syndrome

JNCI : Journal of the National Cancer Institute, 1998-04, Vol.90 (8), p.606-611

1998

Volltextzugriff (PDF)

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D

Breast (Edinburgh), 2022-10, Vol.65, p.32-40

2022

Volltextzugriff (PDF)

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers

Annals of oncology, 2018-04, Vol.29 (4), p.903-909

2018

Volltextzugriff (PDF)

Decision Analysis — Effects of Prophylactic Mastectomy and Oophorectomy on Life Expectancy among Women with BRCA1 or BRCA2 Mutations

The New England journal of medicine, 1997-05, Vol.336 (20), p.1465-1471

1997

Volltextzugriff (PDF)

Germ-line msh6 mutations in colorectal cancer families

Cancer research (Chicago, Ill.), 1999-10, Vol.59 (20), p.5068-5074

1999

Volltextzugriff (PDF)

Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1212-1219

2000

Volltextzugriff (PDF)

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations

JAMA : the journal of the American Medical Association, 2000-02, Vol.283 (5), p.617

2000

Volltextzugriff (PDF)

Occult Ovarian Tumors in Women With BRCA1 or BRCA2 Mutations Undergoing Prophylactic Oophorectomy

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2728-2732

2000

Volltextzugriff (PDF)

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations of BRCA1

The New England journal of medicine, 1996-11, Vol.335 (19), p.1413-1416

1996

Volltextzugriff (PDF)

Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat

American journal of human genetics, 1999-05, Vol.64 (5), p.1371-1377

1999

Volltextzugriff (PDF)

Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations

Annals of internal medicine, 1998-11, Vol.129 (10), p.787

1998

Volltextzugriff (PDF)

Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing

JAMA : the journal of the American Medical Association, 1999-07, Vol.282 (3), p.247

1999

Volltextzugriff (PDF)

Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

Nature genetics, 1994-12, Vol.8 (4), p.387-391

1994

Volltextzugriff (PDF)

Genetic testing in young women with breast cancer: results from a Web-based survey

Annals of oncology, 2010-04, Vol.21 (4), p.741-747

2010

Volltextzugriff (PDF)

Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome

American journal of human genetics, 1995-03, Vol.56 (3), p.608-615

1995

Volltextzugriff (PDF)

Genetic heterogeneity in hereditary breast cancer : Role of BRCA1 and BRCA2

American journal of human genetics, 1996-09, Vol.59 (3), p.547-553

1996

Volltextzugriff (PDF)

1 – 25 von 1.203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.052)
Mit Volltextzugriff
(929)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors

Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

Germline E-cadherin mutations in familial lobular breast cancer

Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1

Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Germ-line p53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers

Multiple primary cancers in families with Li-Fraumeni syndrome

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers

Decision Analysis — Effects of Prophylactic Mastectomy and Oophorectomy on Life Expectancy among Women with BRCA1 or BRCA2 Mutations

Germ-line msh6 mutations in colorectal cancer families

Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations

Occult Ovarian Tumors in Women With BRCA1 or BRCA2 Mutations Undergoing Prophylactic Oophorectomy

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations of BRCA1

Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat

Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations

Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing

Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

Genetic testing in young women with breast cancer: results from a Web-based survey

Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome

Genetic heterogeneity in hereditary breast cancer : Role of BRCA1 and BRCA2

Suchergebnisse filtern